Why “adaptogen” is the most misused word in wellness
The word has a real, narrow scientific definition. Almost every marketing claim that uses it does not meet that definition. Here is the actual standard, and the small set of compounds that pass.
“Adaptogen” has a precise scientific origin. It was coined in 1947 by Soviet pharmacologist Nikolai Lazarev to describe a compound that meets three criteria: it must be non-toxic at the doses used, it must produce a non-specific increase in the body’s resistance to a broad range of stressors, and it must have a normalizing effect — meaning it should counteract dysfunction in either direction.
Almost nothing in the modern adaptogen marketing ecosystem clears all three of those bars.
The shortlist that actually passes
- Ashwagandha (Withania somnifera) — the strongest evidence base, especially for cortisol normalization and subjective stress reduction. KSM-66 and Sensoril are the two extracts with the bulk of the clinical work.
- Rhodiola rosea — meaningful evidence for fatigue reduction and cognitive performance under stress. The active SHR-5 extract is dosed at 200–600 mg.
- Asian ginseng (Panax ginseng) — long history, modest modern evidence base. Variable extract quality is a major caveat.
- Schisandra chinensis — early-stage evidence, mostly from Russian and Chinese literature.
The shortlist that does not pass — but gets called “adaptogen” constantly
- Reishi, lion’s mane, cordyceps — these are functional mushrooms with real bioactivity, but the adaptogen framing is borrowed. They are immunomodulators and nootropics, respectively.
- Maca, holy basil, astragalus — promising, under-studied. The evidence is suggestive, not adaptogenic in the strict sense.
- Anything called “adaptogenic mushroom coffee blend” — almost always sub-clinical doses of multiple ingredients, none of which would meet the criterion individually.
What this means for buying
If a label says “adaptogens” without naming a specific extract at a specific dose, treat it as a marketing word. The compounds that actually meet Lazarev’s definition are dosed in the 300–600 mg range for standardized extracts. Anything below that range is unlikely to produce a measurable effect in a clinical trial.
We sell ashwagandha. We do not call our turmeric “adaptogenic” even though we could get away with it.
Premium supplements you can verify.
Seven formulations. Single-origin sourcing. Third-party tested by two independent labs.
Shop the line →
